UNSPSC 51101911: Halofantrine

This classification denotes an antimalarial agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q2OS4303HZ. European Medicines Agency schedules Halofantrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07998MIG. Halofantrine generally arises in the molecular formula C26H30CL2F3NO.

UNSPSC 51101911 Halofantrine is a Commodity code that nominally covers a specific antimalarial pharmaceutical; however, recent state and local solicitations tagged under this code show minimal direct purchasing of halofantrine itself and instead reflect broader pharmaceutical procurement activity spanning naloxone, over-the-counter products, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription programs. State and local health departments, fire departments, and cooperative purchasing alliances solicit under this code when acquiring pharmaceutical products and related medical supplies for public health, emergency response, and employee benefit programs. The work actually being bought includes emergency medical supplies for first responders, generic pharmaceutical distribution through authorized wholesalers, opioid-reversal agents, and exploratory procurement for alternative pharmacy benefit structures. Issuing bodies range from county health departments and municipal fire services to state health and human services commissions and multistate cooperative purchasing vehicles; no single buyer dominates recent activity.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with bids due July 26, 2023. The City of Tampa's Purchasing Department issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and bids due March 13, 2026, under a small local business enterprise set-aside with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs for state pharmacy benefit initiatives.